Home / Resource Library / Lisocabtagene Maraleucel Achieves Durable Response in R/R Large B-Cell LymphomaLisocabtagene Maraleucel Achieves Durable Response in R/R Large B-Cell Lymphoma Transplantation and Cellular Therapy 2022: